Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Brilaroxazine (RP5063) is a potent multimodal dopamine/5-HT modulator. Brilaroxazine is a partial agonist of dopamine D2, D3, and D4 receptors, 5-HT1A (Ki =1.5 nM) and 5-HT2A (Ki = 2.5 nM), and has antagonist activity 5-HT2B, and 5-HT7 receptors with Kis of 0.19 nM and 2.7 nM, respectively. Brilaroxazine can be used for research about cognitive impairments in neuropsychiatric and neurological diseases.
説明 | Brilaroxazine (RP5063) is a potent multimodal dopamine/5-HT modulator. Brilaroxazine is a partial agonist of dopamine D2, D3, and D4 receptors, 5-HT1A (Ki =1.5 nM) and 5-HT2A (Ki = 2.5 nM), and has antagonist activity 5-HT2B, and 5-HT7 receptors with Kis of 0.19 nM and 2.7 nM, respectively. Brilaroxazine can be used for research about cognitive impairments in neuropsychiatric and neurological diseases. |
ターゲット&IC50 | 5-HT1A receptor:1.5 nM (Ki), 5-HT7 receptor:2.7 nM (Ki), 5-HT2A receptor:2.5 nM (Ki), 5-HT2B receptor:0.19 nM (Ki) |
別名 | RP5063 |
分子量 | 450.36 |
分子式 | C22H25Cl2N3O3 |
CAS No. | 1239729-06-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 95 mg/mL (210.94 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Brilaroxazine 1239729-06-6 GPCR/G Protein Neuroscience Dopamine Receptor 5-HT Receptor Parkinson depressive hypertension cardiac syndrome,ADHD autism inhibit Pulmonary RP5063 PAH Serotonin Receptor Alzheimer RP 5063 Inhibitor RP-5063 disorder,Tourette arterial 5-hydroxytryptamine Receptor inhibitor